UK vs EU Supplement Rules: What Changed After Brexit

Before the UK left the EU single market, a supplement range built for one side of the Channel could usually cross to the other with only a language and address change on the label. That assumption no longer holds. The UK and the EU now run two separate rule-making tracks, and a brand owner who treats them as one market wearing two labels is the brand owner most likely to discover the gap the hard way, mid-production.

The two frameworks still share a common ancestor: UK law at the point of exit carried over the EU rulebook that applied at the time. But every ruling made since exit day has been made once, by one authority, for one market. An ingredient review, a claim decision or a labelling update issued in Brussels after exit does not automatically apply in Great Britain, and the reverse is equally true.

This matters most at the planning stage, before a formula or an artwork file is locked. Deciding early which market you are launching into first, and treating the second market as its own review rather than a copy-paste job, is the main planning habit a dual-market brand owner needs to build.

Northern Ireland is a clear illustration of how much shared ground remains: under the Windsor Framework it continues to follow EU supplement rules for goods placed on its market, while Great Britain runs its own retained-law track. A brand selling into both GB and Northern Ireland is, in effect, already managing a small version of the wider UK/EU split.

Away from that specific case, the starting baseline is genuinely shared. Nutrient and ingredient lists that were harmonised across the EU before exit day were carried into UK law largely intact, so a formula that was compliant on both sides of the Channel on the day of exit is still a reasonable starting point for a dual-market brief today.

Labelling mechanics also still rhyme: both frameworks expect a full ingredient list, allergen information, net quantity and a named responsible party on pack. The details of who that party can be, and what else has to sit next to their name, are where the frameworks start to pull apart, which the next section covers directly.

Since exit day, EU nutrient, claim and novel-food decisions have kept moving on the EU's own schedule, reviewed by EU bodies for the EU market alone. The UK runs a parallel process at its own pace, reviewed by UK bodies for the UK market alone. Two ingredients that entered the shared rulebook identically before exit can now sit on different footings, simply because one authority has acted and the other has not reached the same file yet.

Claims wording is a live example of the same pattern: a claim permitted on the EU's authorised list is not automatically permitted on the UK's own list, and a brand that assumes otherwise risks an artwork reprint after the fact rather than a check before it. The same logic applies to a novel-food determination: a status set for the EU market does not transfer to the UK market and needs its own check.

None of this is a reason to avoid one market or the other. It is a reason to check both registers independently, on their own current terms, rather than assuming a rule confirmed for one side of the Channel already covers the other.

The mechanical labelling requirements, an ingredient list, an allergen declaration, a net quantity, a name and address on pack, look almost identical on both sides of the Channel, which is exactly what makes this section easy to under-plan. The real difference is who can be that named party and where they need to be based, and that difference is not cosmetic.

An EU launch generally expects an EU-based food business operator's details on pack; a GB launch expects a UK-based equivalent. A brand established in only one of the two territories needs to confirm, before artwork is locked, who is standing in that position for the market where they are not established, because your own head office address is not automatically a valid answer on both labels.

Language follows the same one-job-two-rulebooks pattern: the working label language for a given EU market is usually that market's own language rather than English by default, while a GB label is expected in English. Treating translation and the responsible-party question as two separate, parallel checklist items, rather than one generic labelling line, is what keeps a dual-market artwork review from becoming a late surprise.

A permitted claim and a resolved novel-food status are both market-specific findings, not universal facts about an ingredient. Confirming a claim is authorised for the EU says nothing about its UK status, and the reverse is equally true. Each register has to be checked on its own, ideally at the brief stage rather than after a formula is finalised.

This is where a UK+EU launch benefits from being sequenced rather than run as one undifferentiated project. Confirm claims and any novel-food question for whichever market you plan to enter first, then repeat that same check for the second market before that market's artwork is locked. Doing it in that order catches a divergence while it is still a formulation or copy question, not a relabelling one.

The underlying novel-food test, what actually makes an ingredient novel and how that status gets set, is a topic in its own right. The point to carry into a UK+EU launch specifically is that a novel-food finding for one market never automatically covers the other, even for an ingredient both markets already know well.

The efficient way to run a UK+EU launch is one manufacturing brief paired with two parallel compliance reviews, not two separate projects that happen to share a formula. Decide which market goes first, confirm a sample against that market's label and claims requirements, and only then extend the review to the second market rather than trying to clear both at once from a standing start.

Build your artwork brief so the responsible-party details, the label language and any claims wording are variables per market rather than baked into one master file. That structure means a UK-specific or EU-specific correction touches one variable, not the whole artwork, when one market's review lands a different answer than the other.

Keep a sample stage in the sequence even when a formula already exists for one of the two markets. A sample confirms the physical product and the label together, and it is a far cheaper place to catch a mismatch than a print run or a retailer's own compliance check further down the line.

Regardless of how a UK+EU project is sequenced, claims, on-pack labelling, notification filings and ongoing market compliance remain the brand owner's responsibility in both markets; a manufacturing partner supports production and documentation, not the underlying regulatory judgment call. Import duties and customs formalities on either side of the Channel sit with the brand owner or their customs broker in the same way.

The production side of a dual-market launch runs on the same commercial terms regardless of destination. The private-label route starts from 1,000 units for a standard PET bottle or 2,500 units for doypack packaging, and Make it Yours changes flavour, colour or shape on an existing formula without opening a full reformulation project; naming and artwork still follow the standard private-label branding process either way.

Lead time for the physical production run is a planning range of 5–12 weeks depending on format, packaging, production slot and destination, with the exact timeline confirmed during order setup. That is a separate, and usually faster-moving, clock than the compliance review running in parallel on either side of the Channel.

A UK+EU brief works well when it names both markets up front, states which one launches first, and treats the claims, label and novel-food review for the second market as its own line item rather than an afterthought once the first market ships. That single change in how the brief is written is what usually prevents the late-stage surprise a copy-paste artwork brief tends to produce.

Write the two reviews down as separate rows in your own launch plan, each with its own owner and its own check date, even when one person is running both. A UK+EU launch that looks like a single line on a project plan is exactly the kind of launch where one of the two markets quietly slips.

Revisit both rows again shortly before each market's artwork is actually locked, not only at the start of the brief. Rules that were confirmed months earlier can have moved on one side of the Channel without moving on the other, and a short pre-lock check is a cheap way to catch that before the file goes to print.

Format, packaging and destination markets are the details a manufacturing brief needs from you; the claims, label and novel-food review in each market are the details your own regulatory process needs to confirm in parallel, on its own timeline, before either market's artwork is locked for good.